STAT Plus: Pharmalittle: U.S. scientists and Moderna squabble over Covid-19 vaccine; BARDA doles out big coronavirus contract
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
Category: Pharmalot
STAT Plus: Lobbyists tied to President Trump represent more than a dozen companies working on Covid-19
More than a dozen companies developing Covid-19 vaccines, therapies or diagnostics — including several of…
.jpg)
STAT Plus: Johnson & Johnson lowers the price of its TB drug in many poor countries, but is it enough?
After protracted criticism over its pricing for a game-changing tuberculosis medicine, Johnson & Johnson (JNJ)…
STAT Plus: Pharmalittle: Covid-19 trials are marked by disorganization; FDA approves a new type of HIV treatment
Good morning, everyone, and welcome to another working week. We hope the weekend respite, which…
.jpg)
STAT Plus: Alexion to pay $21 million for failing to record bribes paid to doctors in other countries
Alexion Pharmaceuticals (ALXN) agreed to pay more than $21 million for maintaining a false set…
STAT Plus: Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges
And so, another working week will soon come to an end. Not a moment too…
STAT Plus: Novartis pays $678 million to settle a long-running case over alleged kickbacks to doctors
After seven years of sparring, Novartis (NVS) has agreed to pay $678 million to settle…
STAT Plus: Africa Union urges member countries to remove intellectual property barriers to Covid-19 vaccines
Amid growing concern over access to Covid-19 medical products, the organization that represents dozens of…
STAT Plus: Pharmalittle: FDA sets Covid-19 vaccine guidance; White House grabs much of the remdesivir supply
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
Some U.S. government contracts for Covid-19 research could skirt affordable pricing laws
A new report finds that the U.S. government awarded several drug makers contracts for coronavirus research using…
STAT Plus: Indivior CEO pleads guilty in connection with a scheme to promote Suboxone
The chief executive of Indivior pleaded guilty to misbranding Suboxone Film, a medicine used to…
STAT Plus: Canadian court upholds most of a controversial new rule for controlling excessive drug prices
In a setback to the pharmaceutical industry, a federal court judge in Canada has dismissed…
STAT Plus: After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines
U.K. officials and Vertex Pharmaceuticals (VRTX) have finally put to rest a years-long battle over…
STAT+ Conversations: The state of the pharmaceutical industry, featuring Pharmalot’s Ed Silverman
Editor’s note: A livestream of this conversation will be embedded below at 1 p.m. ET. …
STAT Plus: Pharmalittle: FDA to issue guidance on Covid-19 vaccines; what remesdivir pricing may really mean
Top of the morning to you, and a fine one it is. A shiny sun…
STAT Plus: Gilead’s pricing for remdesivir raises questions about the drug’s long-term prospects
After weeks of anticipation, Gilead Sciences (GILD) finally disclosed the pricing for its remdesivir experimental…
STAT Plus: Pharma trade group scolds AstraZeneca for bad behavior over an advisory board
A U.K. pharmaceutical industry trade group has publicly reprimanded AstraZeneca (AZN) for failing to uphold…
STAT Plus: Pharmalittle: Pharma giants plan $1 billion antibiotic venture; Gilead prices remdesivir below most estimates
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharma giants to unveil major $1 billion venture to push novel antibiotics
Amid escalating concerns over antibiotic resistance, several big drug makers are creating a new $1…
STAT Plus: Pharmalittle: Sanofi to cut hundreds of jobs; former BARDA chief claims Azar is sabotaging his new job
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Novartis to pay $345 million to U.S. authorities for bribing doctors in different countries
Novartis (NVS) agreed to pay more than $345 million to resolve criminal charges brought by…
STAT Plus: Pharmalittle: NIH may own patents for the Moderna Covid-19 vaccine; ICER boosts recommended price for remdesivir
Hello, everyone, and how are you this morning? Another balmy day is unfolding here on…
Hospitals see shortages of a cheap steroid that one study says helps Covid-19 patients
After preliminary release of a study found that a cheap steroid reduced deaths by a…
STAT Plus: A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial
Two years ago, French regulators made a surprising decision, overruling one of their own expert…
STAT Plus: Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients
Federal officials on Wednesday alleged that Regeneron Pharmaceuticals (REGN) donated tens of millions of dollars…
STAT Plus: Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: FDA urged to heighten safety warnings on common type 2 diabetes drugs
A consumer advocacy is urging the Food and Drug Administration to heighten warnings about a…
STAT Plus: Pharmalittle: Sanofi steps up Covid-19 vaccine efforts; has a successor to FDA’s Janet Woodcock been found?
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT Plus: Pharmalittle: Will a Covid-19 vaccine protect the elderly? Generic remdesivir to cost up to $79 a dose
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Vertex and Canada hold talks over cystic fibrosis drug, but a deal for newer medicine remains out of reach
The icy relationship between Vertex Pharmaceuticals (VRTX) and the Canadian government is showing signs of…
STAT Plus: Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests
For years, the pharmaceutical industry has maintained that the costs to develop medicines accounts for…
STAT Plus: Pharmalittle: Trump pushes for Covid-19 vaccine by year’s end; Americans fear pharma will keep raising drug prices
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT Plus: A majority of Americans fear pharma will use Covid-19 as an excuse to raise prices
Amid a race to find therapies and vaccines to combat Covid-19, a new poll finds…
Some Covid-19 trial sponsors never posted other study results in an EU database. Will they hide data again?
Amid a wave of research into potential Covid-19 therapies, a new analysis warns that some…
STAT Plus: California attorney general says FTC failed to follow ‘best practices’ in approving AbbVie-Allergan deal
Arguing that the Federal Trade Commission did not follow “best practices” in approving AbbVie’s recent…
STAT Plus: Pharmalittle: White House says Covid-19 vaccine will be free to the ‘vulnerable’; vaccine makers hunt for glass vials
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: As quality concerns rise, FDA report shows Indian drug plants inspected more often — and had more problems
As concerns mount over the quality of the pharmaceutical supply chain, the Food and Drug…
STAT Plus: Pharmalittle: Cheap steroid reduced deaths in severe Covid-19 patients; what the FDA decision on hydroxychloroquine means
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT Plus: A YouTube ‘hit job’ about a Catalyst Pharma rival is posted amid its battle with the FDA
In a move that resembles a scare tactic, a newly posted YouTube video shows a…
STAT Plus: Pharmalittle: Lilly begins studying RA drug for Covid-19; AstraZeneca to provide Europe 400 million vaccine doses
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: A would-be chain of cancer centers wants to treat patients with Right to Try drugs, raising ethical questions
In an unusual move, a private equity firm is soliciting investors to help create a…
STAT Plus: Antimicrobials benefited from expedited FDA programs more than other drugs
Amid concerns over the need for more antimicrobials, a new analysis finds these medicines benefited…
STAT Plus: Pharmalittle: U.S. Chamber wants transparency around Covid-19 vaccines; EU to pump billions into vaccine deals
And so, another working week will soon draw to a close. If you are surprised…
STAT Plus: Pharmalittle: Pfizer CEO says Covid-19 vaccine price won’t be huge; Lilly antibody therapy may be ready by fall
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
STAT Plus: California supports an attorney’s unusual whistleblower lawsuit against ‘fraudulent’ patents
The California insurance commissioner is supporting an unusual gambit by a patent attorney who filed…
STAT Plus: States file a third lawsuit accusing dozens of generic drug makers of price fixing
An ongoing probe by numerous states widened with a new lawsuit accusing more than two…
STAT Plus: Pharmalittle: Fauci encourages fair pricing for Covid-19 products; U.S. plans to start pivotal vaccine trials this summer
Good morning, everyone, and how are you today? The heat continues to rise higher here…
STAT Plus: Many Canadian medical societies fail to disclose industry funding in their clinical guidelines
Many Canadian medical societies and specially focused disease groups fail to disclose industry funding in…
STAT Plus: A judge rules AbbVie isn’t ‘immunized’ from antitrust claims over its Humira patent dealings
In a victory for AbbVie (ABBV), a U.S. federal judge ruled the drug maker did…